New data presented at the American Society of Clinical Oncology meeting show that the HPV vaccine can reduce the risk of HPV-related cancers by 56% in men and 36% in women. Despite the proven efficacy of the vaccine, rates of vaccination in the US remain low. The vaccine not only prevents cervical cancer but also throat, anal, penile, vaginal, and vulvar cancers caused by HPV. Studies show that early vaccination is more effective, yet most people are still not vaccinating. The vaccine has faced skepticism and hesitancy, but it has the potential to prevent tens of thousands of cancer cases each year, making it a crucial preventive measure.
Source link
The HPV vaccine prevents cancer in men, too. Why do so few people get it?
